Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Feasibility of Follow-Up Studies and Reclassification in Spinocerebellar Ataxia Gene Variants of Unknown Significance.
Ghorbani F, Alimohamed MZ, Vilacha JF, Van Dijk KK, De Boer-Bergsma J, Fokkens MR, Lemmink H, Sijmons RH, Sikkema-Raddatz B, Groves MR, Verschuuren-Bemelmans CC, Verbeek DS, Van Diemen CC, Westers H. Ghorbani F, et al. Among authors: groves mr. Front Genet. 2022 Mar 25;13:782685. doi: 10.3389/fgene.2022.782685. eCollection 2022. Front Genet. 2022. PMID: 35401678 Free PMC article.
Afatinib in Osimertinib-Resistant EGFR ex19del/T790M/P794L Mutated NSCLC.
van Kempen LC, Wang H, Aguirre ML, Spatz A, Kasymjanova G, Vilacha JF, Groves MR, Agulnik J, Small D. van Kempen LC, et al. Among authors: groves mr. J Thorac Oncol. 2018 Sep;13(9):e161-e163. doi: 10.1016/j.jtho.2018.04.020. Epub 2018 Apr 25. J Thorac Oncol. 2018. PMID: 29704676 Free article. No abstract available.
New directions in antimalarial target validation.
Batista FA, Gyau B, Vilacha JF, Bosch SS, Lunev S, Wrenger C, Groves MR. Batista FA, et al. Among authors: groves mr. Expert Opin Drug Discov. 2020 Feb;15(2):189-202. doi: 10.1080/17460441.2020.1691996. Epub 2020 Jan 20. Expert Opin Drug Discov. 2020. PMID: 31959021 Review.
Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the Literature.
Koopman B, Groen HJM, Schuuring E, Hiltermann TJN, Timens W, den Dunnen WFA, van den Berg A, Ter Elst A, van Kruchten M, Kluiver JL, Hiddinga BI, Hijmering-Kappelle LBM, Groves MR, Vilacha JF, van Kempen LC, van der Wekken AJ. Koopman B, et al. Among authors: groves mr. Clin Lung Cancer. 2022 Mar;23(2):e104-e115. doi: 10.1016/j.cllc.2021.06.011. Epub 2021 Jul 3. Clin Lung Cancer. 2022. PMID: 34325996 Free article. Review.
Relevance and Effectiveness of Molecular Tumor Board Recommendations for Patients With Non-Small-Cell Lung Cancer With Rare or Complex Mutational Profiles.
Koopman B, van der Wekken AJ, Ter Elst A, Hiltermann TJN, Vilacha JF, Groves MR, van den Berg A, Hiddinga BI, Hijmering-Kappelle LBM, Stigt JA, Timens W, Groen HJM, Schuuring E, van Kempen LC. Koopman B, et al. Among authors: groves mr. JCO Precis Oncol. 2020 Nov;4:393-410. doi: 10.1200/PO.20.00008. JCO Precis Oncol. 2020. PMID: 35050740
Novel Highlight in Malarial Drug Discovery: Aspartate Transcarbamoylase.
Wang C, Krüger A, Du X, Wrenger C, Groves MR. Wang C, et al. Among authors: groves mr. Front Cell Infect Microbiol. 2022 Mar 4;12:841833. doi: 10.3389/fcimb.2022.841833. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35310840 Free PMC article. Review.
Pharmacological Rationale for Targeting IL-17 in Asthma.
Rahmawati SF, Te Velde M, Kerstjens HAM, Dömling ASS, Groves MR, Gosens R. Rahmawati SF, et al. Among authors: groves mr. Front Allergy. 2021 Aug 30;2:694514. doi: 10.3389/falgy.2021.694514. eCollection 2021. Front Allergy. 2021. PMID: 35387016 Free PMC article. Review.
107 results